Litton Edward, Bass Frances, Delaney Anthony, Hillis Graham, Marasco Silvana, McGuinness Shay, Myles Paul S, Reid Christopher M, Smith Julian A
Fiona Stanley Hospital, Perth, WA, Australia.
Royal North Shore Hospital, Sydney, NSW, Australia.
J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2067-2073. doi: 10.1053/j.jvca.2018.01.005. Epub 2018 Jan 5.
To inform the design of a pivotal randomized controlled trial of prophylactic intra-aortic balloon counterpulsation (IABC) in patients undergoing coronary artery bypass graft (CABG) at high risk of postoperative low cardiac output syndrome (LCOS).
Inception cohort study.
A total of 13 established cardiac centers in Australia, Canada, New Zealand, and the United Kingdom.
Adult patients were eligible for inclusion if they were listed for CABG surgery and had 2 or more LCOS risk factors (low ejection fraction, severe left main coronary artery disease, redo sternotomy, unstable angina).
Outcomes of interest were a composite outcome of in-hospital mortality, postoperative acute myocardial infarction (AMI), acute kidney injury (AKI), or stroke as well as 6-month vital status and quality of life using the EuroQol 5-dimensional questionnaire (EQ5D).
The study included 136 participants over a 29-month period. Overall, in-hospital and 6-month mortality occurred in 7 (5%) and 11 (8%) participants, respectively. The composite outcome occurred in 60 (44%). The mean increase in EQ5D summary index at 6 months was 0.10 (standard deviation 0.24, p = 0.01). Perioperative AMI, AKI, or stroke significantly decreased the odds of a clinically meaningful improvement in quality of life (odds ratio 0.32; 95% confidence interval 0.13-0.79; p = 0.014). Preoperative IABC was used in 39 participants and did not predict postoperative outcomes.
The study identified a group of patients at risk of LCOS in whom CABG surgery was associated with a substantial burden of perioperative morbidity. Preoperative IABC use was variable, supporting the need for further research.
为一项关键的随机对照试验提供设计依据,该试验旨在研究预防性主动脉内球囊反搏(IABC)在冠状动脉旁路移植术(CABG)后发生低心排血量综合征(LCOS)高危患者中的应用。
起始队列研究。
澳大利亚、加拿大、新西兰和英国的13个成熟心脏中心。
成年患者若被列入CABG手术名单且有2个或更多LCOS危险因素(低射血分数、严重左主干冠状动脉疾病、再次胸骨切开术、不稳定型心绞痛),则符合纳入标准。
感兴趣的结局为住院死亡率、术后急性心肌梗死(AMI)、急性肾损伤(AKI)或中风的复合结局,以及使用欧洲五维健康量表(EQ5D)评估的6个月时的生命状态和生活质量。
该研究在29个月内纳入了136名参与者。总体而言,住院死亡率和6个月死亡率分别发生在7名(5%)和11名(8%)参与者中。复合结局发生在60名(44%)参与者中。6个月时EQ5D综合指数的平均增加为0.10(标准差0.24,p = 0.01)。围手术期AMI、AKI或中风显著降低了生活质量获得临床意义改善的几率(优势比0.32;95%置信区间0.13 - 0.79;p = 0.014)。39名参与者术前使用了IABC,但这并不能预测术后结局。
该研究确定了一组LCOS高危患者,CABG手术与围手术期较高的发病负担相关。术前IABC的使用情况不一,支持进一步研究的必要性。